Imalumab

Imalumab (BAX69) is a recombinant, human IgG1 monoclonal antibody that targets macrophage inhibitory factor (MIF) . Imalumab can be used for the research of ovarian carcinoma, recurrent malignant ascites and cancer[1].

Product Specifications

CAS Number

[1430205-07-4]

Product Name Alternative

BAX69; Anti-Human MIF Recombinant Antibody

UNSPSC

12352203

Target

Macrophage migration inhibitory factor (MIF)

Type

Inhibitory Antibodies

Related Pathways

Immunology/Inflammation

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/imalumab.html

Purity

98.37

Solubility

10 mM in DMSO

Smiles

[Imalumab]

Molecular Weight

(144.52 kDa)

References & Citations

[1]Bax HJ, et al. Therapeutic targets and new directions for antibodies developed for ovarian cancer. MAbs. 2016 Nov/Dec;8 (8) :1437-1455.|[2]Rossmueller G, et al., Preclinical Evaluation of ON203, A Novel Bioengineered mAb Targeting Oxidized Macrophage Migration Inhibitory Factor as an Anticancer Therapeutic. Mol Cancer Ther. 2023 May 4;22 (5) :555-569.